EternoGen EternoGen is a regenerative medicine Bio-Tech company with a focus on designing, manufacturing and commercializing novel stimulatory collagen-nanoparticle scaffolds for soft tissue therapeutic applications. The mission of the company is to provide superior collagen-based products for a variety of minimally invasive surgical applications by leveraging expertise in applied nanotechnology and soft tissue engineering.
Location: United States, Missouri, Columbia
Investors 1
| Date | Name | Website |
| - | Missouri T... | missourite... |
Mentions in press and media 2
| Date | Title | Description |
| 25.07.2013 | Missouri startup raises near $1M to commercialize novel collagen scaffold for soft tissue therapeutic applications | “In an aesthetic market, we can be in the market at the end of 2014,” Jimenez said, emphasizing the technology being “extremely close” to commercialization. The medical implications beyond cosmetic surgery are many, Jimenez said. The nanome... |
| - | Missouri startup raises near $1M to commercialize novel collagen scaffold for soft tissue therapeutic applications | Dermelle, LLC (aka EternoGen, LLC), a Columbia, Missouri-based startup that works with collagen scaffolds for soft tissue therapeutic applications, has raised $920,427 to close its series A funding. This money will pay for the “full spectru... |